Telix Pharmaceuticals

About Telix Pharmaceuticals

Telix Pharmaceuticals is a global biopharmaceutical company developing diagnostic and therapeutic radiopharmaceuticals, focused on theranostics for cancer and rare diseases. The company leverages targeted radiation to inform treatment decisions and deliver personalized therapy, with an established global supply, manufacturing and distribution network. Telix operates across oncology sub-specialties including prostate and kidney cancers, glioma, musculoskeletal cancers, and bone marrow conditioning, with regulatory approvals in major markets and an active clinical trial program. Headquartered in Australia, Telix emphasizes advancing imaging and therapeutic radiopharmaceuticals to improve patient outcomes worldwide.